Biologics Modular has created modular cleanroom technology for use in developing or manufacturing CGMP products, which can be moved between various research, development and production locations.
Legal firm Woodard, Emhardt, Moriarty, McNett & Henry has filed a utility patent application on behalf of the firm, which is based in Brownsburg, Indiana, US.
Clark Byrum, president and ceo of Biologics Modular, said the technology gives small companies and research parks have access to cleanroom capabilities that were once thought only to be available to large corporations.
“The ability to deliver cost effective, high quality manufacturing and laboratory facilities will enhance the progression of research, development, and small-scale manufacturing,” he said.
In a matter of months, any light industrial space can be converted into an operational CGMP production facility using Biologics Modular’s cleanroom and analytical laboratory designs.
Biologics Modular files patent for mobile modular cleanroom
For use in the development of CGMP products
You may also like
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
Design & Build
Deadline is approaching to submit applications for FDA’s PreCheck Pilot Program for pharma industries
The US Food and Drug Administration has opened applications for a scheme to give pharmaceutical manufacturers early guidance for developing new facilities, which will close on March 1
Design & Build
Monmouth Scientific to showcase Modular Cleanrooms at Space-Comm Expo Europe
At Space-Comm Expo Europe, taking place on 4–5 March 2026 at ExCeL London, Monmouth Scientific will showcase its ISO Class Modular Cleanrooms, delivering controlled environments for satellite assembly, advanced materials research, and other critical aerospace processes — providing confidence in both safety and reliability